• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Aminopyrimidines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Aminopyrimidines and derivatives

2-Pyrimidinamine, 5-(1,1-dimethylethyl) (CAS No. 94615-68-6): An Overview of Its Properties and Applications

2-Pyrimidinamine, 5-(1,1-dimethylethyl) (CAS No. 94615-68-6) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 5-(tert-butyl)pyrimidin-2-amine, is characterized by its unique structural features and potential biological activities. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, and recent advancements in the study of 2-Pyrimidinamine, 5-(1,1-dimethylethyl).

Chemical Structure and Properties

2-Pyrimidinamine, 5-(1,1-dimethylethyl) is a derivative of pyrimidine, a heterocyclic aromatic organic compound. The molecular formula of this compound is C₉H₁₃N₃, and its molecular weight is approximately 167.22 g/mol. The presence of the tert-butyl group at the 5-position of the pyrimidine ring imparts unique physical and chemical properties to the molecule. This tert-butyl substituent enhances the lipophilicity and stability of the compound, making it an attractive candidate for various pharmaceutical applications.

The compound is a white crystalline solid at room temperature and is soluble in common organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO). Its melting point is around 90-92°C. The solubility and melting point characteristics are crucial for its use in drug development processes, including formulation and delivery.

Synthesis Methods

The synthesis of 2-Pyrimidinamine, 5-(1,1-dimethylethyl) has been extensively studied and can be achieved through several synthetic routes. One common method involves the reaction of 2-chloropyrimidine with tert-butylamine in the presence of a base such as potassium carbonate. This reaction typically proceeds via nucleophilic substitution to form the desired product. Another approach involves the condensation of guanidine with tert-butylglyoxal followed by cyclization to form the pyrimidine ring.

Recent advancements in green chemistry have led to the development of more environmentally friendly synthetic methods for 2-Pyrimidinamine, 5-(1,1-dimethylethyl). For instance, microwave-assisted synthesis has been shown to significantly reduce reaction times and improve yields while minimizing waste production. These green synthetic strategies are increasingly important in modern pharmaceutical research to ensure sustainability and environmental responsibility.

Biological Activities and Applications

2-Pyrimidinamine, 5-(1,1-dimethylethyl) has been investigated for its potential biological activities in various therapeutic areas. One of the most promising applications is in the field of anticancer drug development. Studies have shown that this compound exhibits significant antiproliferative effects against several cancer cell lines, including breast cancer, lung cancer, and colon cancer cells. The mechanism of action appears to involve the inhibition of key signaling pathways involved in cell proliferation and survival.

In addition to its anticancer properties, 2-Pyrimidinamine, 5-(1,1-dimethylethyl) has also been explored for its anti-inflammatory effects. Research has demonstrated that this compound can effectively reduce inflammation by inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These findings suggest potential applications in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Clinical Trials and Future Prospects

The promising preclinical results for 2-Pyrimidinamine, 5-(1,1-dimethylethyl) have led to increased interest in advancing this compound into clinical trials. Several phase I trials are currently underway to evaluate its safety and efficacy in human subjects. Early results from these trials have been encouraging, with no significant adverse effects reported at therapeutic doses.

In parallel with clinical trials, ongoing research is focused on optimizing the pharmacokinetic properties of 2-Pyrimidinamine, 5-(1,1-dimethylethyl) to enhance its bioavailability and reduce potential side effects. Strategies such as prodrug design and nanoparticle formulations are being explored to improve drug delivery and target specificity.

Conclusion

2-Pyrimidinamine, 5-(1,1-dimethylethyl) (CAS No. 94615-68-6) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure confers favorable physical properties that make it suitable for drug development. Recent studies have highlighted its antiproliferative and anti-inflammatory activities, paving the way for further clinical investigation.

Ongoing research aims to optimize its pharmacological properties and explore new therapeutic indications. As our understanding of this compound continues to evolve, it holds great promise for addressing unmet medical needs in various disease areas.

• 98432-17-8(5-(propan-2-yl)pyrimidin-2-amine)
• 90253-43-3(2-Pyrimidinamine, 5-cyclobutyl-)
• 39268-71-8(5-Ethylpyrimidin-2-amine)
• 127473-63-6(2-Pyrimidinamine,5-(1-methylpropyl)-, (S)- (9CI))
• 33115-31-0(Pyrimidine,5-(1-methylethyl)-)
• 73549-64-1(5-cyclohexylpyrimidin-2-amine)
• 90253-45-5(2-Pyrimidinamine, 5-cycloheptyl-)
• 90253-44-4(2-Pyrimidinamine, 5-cyclopentyl-)
• 90008-44-9(2-Pyrimidinamine,5-ethyl-N-methyl-)
• 84822-63-9(Pyrimidine,5-(1,1-dimethylethyl)-)